Results 91 to 100 of about 6,337 (198)

13 Cities, 26 Days, 10,000 Miles: Cedarville University Hits the Road [PDF]

open access: yes, 2022
It’s not every day that a university takes its message and vision for higher education on the road. But that’s exactly what Cedarville University, a private Christian university located between Columbus and Dayton, Ohio, will do this summer when it ...
Weinstein, Mark D.
core   +1 more source

Pandora’s box: Paxlovid, prescribing, pharmacists and pandemic [PDF]

open access: yesJournal of Pharmacy Practice and Research, 2022
Jason A, Roberts   +2 more
openaire   +2 more sources

Option contracts in health care: the Paxlovid case associated with Covid-19 [PDF]

open access: yes
openL'utilizzo dei contratti d'opzione in ambito sanitario è assai recente, perciò l'acquisto da parte di istituzioni sanitarie di questi strumenti finanziari per l'approvvigionamento di farmaci, come ad esempio gli antivirali, è limitato.
TESTI, TOMMASO
core  

Peace, love, Paxlovid and ‘Pfizermectin’

open access: yes, 2021
As the new Omicron variant of concern of COVID-19 emerged over Thanksgiving week (of all times!), attention has been turning to Paxlovid (PF-07321332). If, like me, you torment yourself by perusing conspiracy theories, you might have heard it referred to as Pfizermectin.
openaire   +1 more source

Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor [PDF]

open access: yesJournal of Nephropharmacology, 2022
Alireza Pouramini   +7 more
doaj   +1 more source

In Silico Evaluation of Paxlovid’s Pharmacometrics for SARS-CoV-2: A Multiscale Approach [PDF]

open access: yes, 2022
Bartha Ferenc Ágoston   +4 more
core   +1 more source

Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study

open access: yesJournal of Infection and Public Health
Background: COVID-19 pneumonia has spread across China and globally since late 2019, becoming a pandemic. Its extremely contagious nature as well as high morbidity and mortality rates have attracted widespread attention globally.
Wei Yang   +6 more
doaj   +1 more source

A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. [PDF]

open access: yes
Paxlovid ®, the only orally available COVID drug, consists of two main components: Nirmatrelvir and Ritonavir. Ritonavir is known for the potent inhibition of CYP (cytochrome P450) enzymes in the liver mainly of CYP3A4, resulting in a large number of ...
Gray, Gwen   +4 more
core   +1 more source

A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019 [PDF]

open access: yes
BackgroundTo address the need for treatments for patients with coronavirus disease 2019 (COVID-19), 3 therapies have been given either full approval or Emergency Use Authorization.
Haslam, Alyson, Prasad, Vinay
core   +1 more source

Recomanacions per a l’inici i el seguiment del tractament amb Paxlovid® per a pacients amb COVID-19 lleu-moderada amb risc alt de progressar a formes greus [PDF]

open access: yes, 2022
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Paxlovid; Medicament antiviralCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Paxlovid; Medicamento antiviralCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Paxlovid; Antiviral medicationRecomanacions per a l’inici ...

core  

Home - About - Disclaimer - Privacy